197 related articles for article (PubMed ID: 15312409)
1. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409
[TBL] [Abstract][Full Text] [Related]
2. [Study of CYP3A5 in drug resistance mechanisms in acute leukemia].
Wang T; Chen FY; Han JY; Shao NX; Ou-Yuang RR
Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):286-9. PubMed ID: 12859862
[TBL] [Abstract][Full Text] [Related]
3. [Transfection of HL-60 cells with CYP3A5 gene induces drug-resistant phenotype].
Wang T; Chen FY; Gu CH; Zhong H; Teng Y; Ouyang RR
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):461-4. PubMed ID: 16188140
[TBL] [Abstract][Full Text] [Related]
4. [Combined effect of recombinant mutant human TRAIL and daunorubicin in inducing apoptosis of leukemia cell and its mechanism].
Zhang XJ; Wen L; Wang FX; Luo JM; Pan L; Liu XJ; DU XY; Dong ZR; Yang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1123-8. PubMed ID: 17204177
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
6. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM].
Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR
Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547
[TBL] [Abstract][Full Text] [Related]
7. LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.
Yao Q; Zhang L; Wang Y; Liu J; Yang L; Wang Y
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33969374
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.
Nishida Y; Mizutani N; Inoue M; Omori Y; Tamiya-Koizumi K; Takagi A; Kojima T; Suzuki M; Nozawa Y; Minami Y; Ohnishi K; Naoe T; Murate T
Biochim Biophys Acta; 2014; 1839(4):265-74. PubMed ID: 24530422
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.
Styczynski J; Wysocki M; Balwierz W; Kowalczyk JR
Leukemia; 2002 May; 16(5):820-5. PubMed ID: 11986942
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant VEGF-C secreted from eukaryotic cells on proliferation and chemotherapy-induced apoptosis of leukemic cells].
Ding KY; Bai X; Dai L; Dong NZ; Ruan CG
Ai Zheng; 2005 Sep; 24(9):1037-42. PubMed ID: 16159421
[TBL] [Abstract][Full Text] [Related]
12. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells.
Wu YH; You Y; Chen ZC; Zou P
Acta Biochim Pol; 2008; 55(4):673-80. PubMed ID: 19093040
[TBL] [Abstract][Full Text] [Related]
13. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
[TBL] [Abstract][Full Text] [Related]
14. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
Jiang HN; Liu ZG; Hu R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
[TBL] [Abstract][Full Text] [Related]
15. [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells].
Liu YH; Wang ZY; Dai L; Shen WH; Cen JN; Zhang W; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2010 Dec; 31(12):813-6. PubMed ID: 21223737
[TBL] [Abstract][Full Text] [Related]
16. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
Lotfi K; Zackrisson AL; Peterson C
Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Zheng B; Zhou R; Gong Y; Yang X; Shan Q
Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
[TBL] [Abstract][Full Text] [Related]
19. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
20. [Effect of daunorubicin and cytarabine on cell line NB4].
Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
